Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and impaired insulin secretion.
Khan SR, Ye WW, Van JAD, Singh I, Rabiee Y, Rodricks KL, Zhang X, Nicholson RJ, Razani B, Summers SA, Futerman AH, Gunderson EP, Wheeler MB.
Khan SR, et al. Among authors: zhang x.
Sci Adv. 2025 Jan 10;11(2):eadr1725. doi: 10.1126/sciadv.adr1725. Epub 2025 Jan 10.
Sci Adv. 2025.
PMID: 39792658